The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 18, 2024

Filed:

Nov. 09, 2018
Applicant:

Inflazome Limited, Dublin, IE;

Inventors:

Matthew Cooper, Cambridge, GB;

David Miller, Cambridge, GB;

Angus Macleod, Cambridge, GB;

Stephen Thom, Nottingham, GB;

Stephen St-Gallay, Nottingham, GB;

Jonathan Shannon, Nottingham, GB;

Ian Strutt, Nottingham, GB;

Assignee:

INFLAZOME LIMITED, Dublin, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/06 (2006.01); A61P 29/00 (2006.01); C07D 231/18 (2006.01); C07D 233/84 (2006.01); C07D 249/04 (2006.01); C07D 249/12 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07D 401/06 (2013.01); A61P 29/00 (2018.01); C07D 231/18 (2013.01); C07D 233/84 (2013.01); C07D 249/04 (2013.01); C07D 249/12 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/04 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/06 (2013.01);
Abstract

The present invention relates to sulfonylureas and sulfonylthioureas comprising as-membered nitrogen-containing heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is substituted with at least one group containing an oxygen atom, and wherein said oxygen atom is attached to the heteroaryl ring via at least two other atoms. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.


Find Patent Forward Citations

Loading…